Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional Validation

Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional Validation

<div><p>Triple-negative breast cancer (TNBC) patients exhibiting pathological complete response (pCR) have better clinical outcomes compared to those with residual disease (RD). Therefore, robust biomarkers that can predict pCR may help with triage and resource prioritization in patients...

Full description

Saved in:
Bibliographic Details
Main Author: Radhakrishnan Vishnubalaji (3563306) (author)
Other Authors: Hikmat Abdel-Razeq (16706589) (author), Salahddin Gehani (18426864) (author), Omar M. E. Albagha (11704871) (author), Nehad M. Alajez (7397276) (author)
Published: 2022
Subjects:
Chemical sciences
Inorganic chemistry
Organic chemistry
Physical chemistry
Theoretical and computational chemistry
TNBC
neoadjuvant chemotherapy
predictive biomarkers
pathological complete response
residual disease
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items